VOVSNCT03346889
Vestibular Outcomes in Vestibular Schwannoma
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 6 with changes below, 2 re-verified with no change.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting
- Minor Study completion date: Dec 31, 2023 to Dec 31, 2025v8
- Minor Primary completion date changed from estimate of Dec 31, 2022 to Jun 25, 2019
- Study completion date: Dec 31, 2022 to Dec 31, 2023
- Notable Primary and study completion dates: Dec 31, 2021 to Dec 31, 2022v6
- Notable Primary and study completion dates: Dec 31, 2019 to Dec 31, 2021
- Trial status: Recruiting to Active, Not Recruiting
- Enrollment target: estimated 150 to confirmed 155
- Site details revised
- Notable Primary and study completion dates pushed to Dec 31, 2019v3
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Dizziness Handicap Inventory (DHI)
Timeframe: Baseline and 1-year follow-up
Secondary (5)
Vertigo Symptom Scale Short Form
Haukeland Dizziness Questionnaire (HDQ-10)
Vertigo Visual Analog Scale
Hospital Anxiety and Depression Scale (HADS)
RAND-12
Sites
1 site in 1 country
- Haukeland University HospitalBergen, Hordaland, Norway